Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2010
05/06/2010WO2010048705A1 Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng
05/06/2010WO2010048701A1 Ingestibles containing sugar and cinnamon or ginseng
05/06/2010WO2010029089A3 Combination therapy for the treatment of diabetes and related conditions
05/06/2010WO2010014889A3 Nitro fatty acids as regiomers and related mimetics
05/06/2010WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
05/06/2010WO2010011836A3 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof
05/06/2010WO2010005961A3 Nutritive compositions and methods of using same
05/06/2010WO2009158031A3 Methods and compositions for therapeutic treatment
05/06/2010WO2009144278A3 Conglutin-gamma as medicament and diet supplement
05/06/2010US20100113820 asthma, allergic conditions such as rhinitis, inflammatory bowel disease such as ulcerative colitis and Crohn's disease, rheumatoid arthritis, atopic dermatitis, multiple sclerosis; condensing N-(2,6-Difluorobenzoyl)-4-(2,6-dimethoxy-4-formal methylphenyl)-L-phenylalanine ethyl ester with ethanol
05/06/2010US20100113796 Indole derivatives as s1p1 receptor
05/06/2010US20100113750 Novel scavenger receptor
05/06/2010US20100113749 Novel scavenger receptor
05/06/2010US20100113603 Combination therapies for the treatment of obesity
05/06/2010US20100113587 use of abscissic acid to treat various diseases, including neurodegenerative and neuromuscular diseases
05/06/2010US20100113583 Combination therapies for the treatment of obesity
05/06/2010US20100113581 Combination therapies for the treatment of obesity
05/06/2010US20100113580 Combination therapies for the treatment of obesity
05/06/2010US20100113556 Novel crystal forms of pyrrolylheptanoic acid derivatives
05/06/2010US20100113549 Pyrrolidine compounds
05/06/2010US20100113546 Imidazol-4-one and Imidazole-4-thione Compounds
05/06/2010US20100113541 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
05/06/2010US20100113536 haloalkylsulfone substituted compounds useful for treating obesity and diabetes
05/06/2010US20100113532 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113492 Substituted Aminopyrimidines as Cholecystokinin-1 Receptor Modulators
05/06/2010US20100113489 Modulators of chemokine receptor activity, crystalline forms and process
05/06/2010US20100113487 Pyrimidinone derivatives and methods of use thereof
05/06/2010US20100113480 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
05/06/2010US20100113479 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
05/06/2010US20100113473 Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor
05/06/2010US20100113463 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
05/06/2010US20100113449 Fused heterocyclic compounds as ion channel modulators
05/06/2010US20100113448 Oxazolidinone derivative having inhibitory activity on 11beta-hydroxysteroid dehydrogenase type 1
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113433 N-Substituted Thiomorpholine Derivatives as the Inhibitors of Dipeptidyl Peptidase IV and the Pharmaceutical Uses Thereof
05/06/2010US20100113418 Heterocyclic compound
05/06/2010US20100113417 Substituted Spiroamine Compounds
05/06/2010US20100113412 IMIDAZO[1,2-a]PYRIDINES AND THEIR USE AS PHARMACEUTICALS
05/06/2010US20100113394 Low dosage forms of risedronate or its salts
05/06/2010US20100113390 Oligosaccharides derived from fucoidan
05/06/2010US20100113384 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
05/06/2010US20100113382 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener
05/06/2010US20100113375 Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, alpha-amylase and alpha-glucosidase activity in mammals
05/06/2010US20100113374 Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, alpha-amylase and alpha-glucosidase activity in mammals
05/06/2010US20100113363 Use of GLP-1 Peptides
05/06/2010US20100113347 Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes
05/06/2010US20100113333 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
05/06/2010US20100113331 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors
05/06/2010US20100113330 Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof
05/06/2010US20100112162 25-Hydroxy vitamin D3 compositions
05/06/2010US20100111974 Treatment of Cachexia
05/06/2010US20100111940 Compositions containing alpha-1-antitrypsin and methods for use
05/06/2010US20100111933 Acid soluble proteins from micellar casein
05/06/2010US20100111902 Composition for transmucosal delivery of polypeptides
05/06/2010US20100111897 Methods and Compositions Useful for Diabetic Wound Healing
05/06/2010US20100111853 Antibodies that bind to il-12 and methods of purifying the same
05/06/2010CA2742181A1 Statin nanoparticles
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/06/2010CA2741517A1 Thyroid receptor ligands
05/06/2010CA2740058A1 An antidiabetic agent
05/06/2010CA2739712A1 Peptide having anti-diabetic activity and use thereof
05/05/2010EP2180894A1 Methods of activating irs-1 and akt
05/05/2010EP2180889A1 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control
05/05/2010EP2180787A1 Nitrated-fatty acids modulation of type ii diabetes
05/05/2010EP1957452B1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
05/05/2010EP1891001B1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS
05/05/2010EP1790655B1 Biologically active peptides
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/05/2010EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders
05/05/2010EP1227803B1 compounds for inhibiting iapp-associated amyloid deposits
05/05/2010EP1167366B1 Amine derivatives
05/05/2010CN1947792B Method for preparing active protein composition type nano-selenium and its liquid phase storage tech.
05/05/2010CN1921875B Beverage and medicine having bamboo extractive as main component
05/05/2010CN1919214B Monascus soft capsule and its preparation method
05/05/2010CN1891229B Medicinal composition for preventing or treating metabolic syndrome
05/05/2010CN1861104B Inula flower extractive used to breat diabets mellitus and hyperlipidemia
05/05/2010CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease
05/05/2010CN1745792B Compound Chinese medicine for regulating blood fat and blood sugar
05/05/2010CN1736456B Extracts of composite Chinese medicinal plants for treating diabetic gastrointestinal disease and preparation thereof
05/05/2010CN1682707B Pharmaceutical composition comprising fenofibrate and process for its preparation
05/05/2010CN1679912B Extraction of liuwei Dihuang polysaccharide, products and use thereof
05/05/2010CN1630629B 酯化合物及其医药用途 Ester compounds and pharmaceutical use
05/05/2010CN1630526B Systems and methods for treating patients with processed lipoaspirate cells
05/05/2010CN1420924B Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof
05/05/2010CN101702884A Therapy for hyperglycemia, related disorders and erectile dysfunction
05/05/2010CN101701218A Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof
05/05/2010CN101700397A Tibetan medicine composite for treating diabetes and preparation method of preparation thereof
05/05/2010CN101700364A Thrombolytic and lipid-lowering pill
05/05/2010CN101700354A Traditional Chinese medicine for treating diabetes
05/05/2010CN101700341A Biological composition for nourishing kidney and protecting liver and preparation method for oral liquid thereof
05/05/2010CN101700324A Method for preparing drug for curing type II diabetes mellitus
05/05/2010CN101700310A Compound traditional Chinese medicine preparation of worm grass for reducing blood sugar
05/05/2010CN101700309A Chinese materia medica preparation for invigorating premodial energy and decreasing blood glucose
05/05/2010CN101700269A Compound capsule of climbing entada seed for reducing blood sugar, preparation method and application thereof
05/05/2010CN101700265A Application of pseudo-ginseng and extract thereof in preparing medicament for curing and/or preventing diabetic microangiopathies
05/05/2010CN101700264A Application of pseudo-ginseng and extract thereof in preparing medicament for curing and/or preventing diabetic neuropathies
05/05/2010CN101700256A Pharmaceutical composite for reducing blood fat
1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 1298